Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China flag China · Delayed Price · Currency is CNY
7.16
-0.05 (-0.69%)
May 20, 2026, 1:45 PM CST

SHE:002349 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
848.82854.921,014921.76933.27651.59
Trading Asset Securities
395.67434.74105.16317.7124.95213.36
Cash & Short-Term Investments
1,2441,2901,1191,2391,058864.95
Cash Growth
5.16%15.28%-9.74%17.13%22.35%24.26%
Accounts Receivable
458.09417.83414.58387.67339.16355.87
Other Receivables
1.411.682.680.682.717.19
Receivables
459.5419.5417.26388.35341.86373.06
Inventory
275.07277.32270.35290.94307.65323.12
Other Current Assets
45.2840.6137.9567.0621.3133.93
Total Current Assets
2,0242,0271,8441,9861,7291,595
Property, Plant & Equipment
555.35565.16616.38663.36708.421,169
Long-Term Investments
-497.65356.9940.0246.9720.99
Goodwill
167.94167.94167.94167.94167.94167.94
Other Intangible Assets
58.1658.6860.5262.5365.06123.24
Long-Term Deferred Tax Assets
7.056.985.986.2212.5914.88
Long-Term Deferred Charges
-----37.92
Other Long-Term Assets
816.73246.84249.67259.13267.8925.01
Total Assets
3,6303,5703,3023,1853,0423,198
Accounts Payable
139.88155.4148.44141.94139.61213.06
Accrued Expenses
50.22133.43115.71123.65140.77107.69
Short-Term Debt
3.151.6810.4320.9221.0368.78
Current Portion of Long-Term Debt
-----120.16
Current Portion of Leases
-0.420.751.180.681.77
Current Income Taxes Payable
28.546.7411.1613.612.047.95
Current Unearned Revenue
13.1712.2211.4413.645.130.43
Other Current Liabilities
130.2184.927.6546.6235.4153.39
Total Current Liabilities
365.17394.79325.58361.51394.63603.24
Long-Term Leases
2.171.680.20.430.913.88
Long-Term Unearned Revenue
12.6712.9611.7310.8410.659.5
Long-Term Deferred Tax Liabilities
9.949.487.157.9612.0211.93
Other Long-Term Liabilities
2.312.23----
Total Liabilities
392.26421.13344.66380.75418.22628.54
Common Stock
829.67829.67814.18814.18814.18835.72
Additional Paid-In Capital
828.43823.47769769905.921,017
Retained Earnings
1,2151,149995.01860.5677.94514.59
Treasury Stock
-55.49-55.49----132.2
Comprehensive Income & Other
6.795.95.30.912.891.14
Total Common Equity
2,8242,7532,5832,4452,4012,236
Minority Interest
412.87396.5373.63359.67222.77333.72
Shareholders' Equity
3,2373,1492,9572,8042,6242,570
Total Liabilities & Equity
3,6303,5703,3023,1853,0423,198
Total Debt
5.323.7711.3822.5422.62194.59
Net Cash (Debt)
1,2391,2861,1071,2171,036670.36
Net Cash Growth
5.66%16.12%-9.00%17.51%54.48%34.21%
Net Cash Per Share
1.511.571.361.491.270.82
Filing Date Shares Outstanding
814.25827.42814.18814.18814.18814.18
Total Common Shares Outstanding
814.25827.42814.18814.18814.18814.18
Working Capital
1,6591,6321,5191,6241,334991.83
Book Value Per Share
3.473.333.173.002.952.75
Tangible Book Value
2,5982,5262,3552,2142,1681,945
Tangible Book Value Per Share
3.193.052.892.722.662.39
Buildings
-577.17575570.97567.6949.94
Machinery
-668.15638.6618.06619.1695.42
Construction In Progress
-27.0753.5769.4261.5159.36
Source: S&P Global Market Intelligence. Standard template. Financial Sources.